Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen

(2012) Paul M Ridker et al.   CIRCULATION

Systematic Review of Tocilizumab for Rheumatoid Arthritis: A New Biologic Agent Targeting the Interleukin-6 Receptor

(2012) Iris Navarro-Millán et al.   CLINICAL THERAPEUTICS

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

(2012)   LANCET

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

(2012)   LANCET

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

(2011) Paul M Ridker et al.   AMERICAN HEART JOURNAL

IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer

(2011) Markus F. Neurath et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women

(2011) B. J. JEFFERIS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Progress and challenges in translating the biology of atherosclerosis

(2011) Peter Libby et al.   NATURE

Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE

(2011) Deborah P. M. Symmons et al.   Nature Reviews Rheumatology

The cohorts at the Research Centre for Prevention and Health, formerly 'The Glostrup Population Studies'

(2010) M. Osler et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Averting inflammation by targeting the cytokine environment

(2010) Manfred Kopf et al.   NATURE REVIEWS DRUG DISCOVERY

IL-17 and Th17 Cells

(2009) Thomas Korn et al.   Annual Review of Immunology

Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women

(2009) Barbara J. Jefferis et al.   ATHEROSCLEROSIS

Lack of association between polymorphisms of the IL18R1 and IL18RAP genes and cardiovascular risk: the MORGAM Project

(2009) Marie-Lise Grisoni et al.   BMC Medical Genetics

Do inflammatory biomarkers add to the discrimination of cardiovascular disease after allowing for social deprivation? Results from a 10-year cohort study in Glasgow, Scotland

(2009) M. Woodward et al.   EUROPEAN HEART JOURNAL

Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease

(2009) Paul Elliott   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)

(2009) PAUL M. RIDKER   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Role for TNF in atherosclerosis? Lessons from autoimmune disease

(2009) Gayle E. McKellar et al.   Nature Reviews Cardiology

Circulating TNFα levels in older men and women do not show independent prospective relations with MI or stroke

(2008) Barbara J. Jefferis et al.   ATHEROSCLEROSIS

Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry

(2008) Albert Marni Joensen et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Inflammatory Mechanisms: The Molecular Basis of Inflammation and Disease

(2008) Peter Libby   NUTRITION REVIEWS

Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men

(2008) P. Welsh et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review

(2008) John Danesh et al.   PLOS MEDICINE